Table 4.
Medications on admission and prescribed at discharge
| Total | NSTEMI | STEMI | P value* | |
|---|---|---|---|---|
| Medications on admission, n (%) | ||||
| Antiplatelet agents | ||||
| Acetyl salicylic acid | 534 (29.8) | 395 (35.3) | 139 (20.7) | <0.001 |
| Clopidogrel | 208 (11.6) | 168 (15) | 40 (6) | <0.001 |
| Ticagrelor | 26 (1.5) | 18 (1.6) | 8 (1.2) | 0.475 |
| Prasugrel | 3 (0.2) | 2 (0.2) | 1 (0.1) | -† |
| Beta blockers | 397 (22.2) | 311 (27.8) | 86 (12.8) | <0.001 |
| Calcium antagonists | 243 (13.6) | 170 (15.2) | 73 (10.9) | 0.010 |
| Nitrates | 70 (3.9) | 64 (5.7) | 6 (0.9) | <0.001 |
| Anti-lipid agents | 256 (14.3) | 203 (18.2) | 53 (7.9) | <0.001 |
| ACE inhibitors | 284 (15.9) | 205 (18.3) | 79 (11.8) | <0.001 |
| Medications prescribed at discharge, n (%) | ||||
| Antiplatelet agents | ||||
| Acetyl salicylic acid | 1830 (99.3) | 1141 (99) | 689 (99.9) | 0.038 |
| Clopidogrel | 930 (50.5) | 689 (59.8) | 241 (34.9) | <0.001 |
| Ticagrelor | 750 (40.7) | 354 (30.7) | 396 (57.4) | <0.001 |
| Prasugrel | 58 (3.1) | 22 (1.9) | 36 (5.2) | <0.001 |
| Dual antiplatelet therapy | 1731 (94) | 1059 (91.9) | 672 (97.4) | <0.001 |
| Anticoagulant agents | 68 (3.5) | 53 (4.4) | 15 (2) | |
| Warfarin | 28 (1.5) | 21 (1.8) | 7 (1) | |
| Dabigatran | 7 (0.4) | 6 (0.5) | 1 (0.1) | 0.270 |
| Rivaroxaban | 9 (0.5) | 6 (0.5) | 3 (0.4) | 1,000 |
| Apiksaban | 20 (1.1) | 17 (1.4) | 3 (0.4) | 0.040 |
| Edoxaban | 4 (0.2) | 3 (0.3) | 1 (0.1) | -† |
| Beta blockers | 1544 (85.0) | 965 (84.5) | 579 (85.9) | 0.418 |
| Calcium antagonists | 246 (13.5) | 192 (16.8) | 54 (8.0) | <0.001 |
| Anti-lipid agents | 1756 (96.3) | 1103 (96.2) | 653 (96.3) | 0.944 |
| Diuretics | 298 (16.4) | 204 (17.9) | 94 (13.9) | 0.029 |
| ACE inhibitors | 1061 (58.4) | 645 (56.5) | 416 (61.7) | 0.029 |
| Angiotension receptor blockers | 144 (7.9) | 103 (9.0) | 41 (6.1) | 0.025 |
| Digitalis | 9 (0.5) | 7 (0.6) | 2 (0.3) | 0.498 |
| Anti-arrhythmic agents | 24 (1.3) | 16 (1.4) | 8 (1.2) | 0.700 |
| Nitrates | 152 (8.4) | 124 (10.9) | 28 (4.2) | <0.001 |
| Anti-diabetic agents | 208 (11.5) | 145 (12.7) | 63 (9.3) | 0.030 |
*
P value denotes the comparison of STEMI and NSTEMI.
†
Not analyzed.
ACE - angiotension converting enzyme; NSTEMI - non-ST elevation myocardial infarction; STEMI - ST elevation myocardial infarction